Clinical trial
Feasibility Study of Connective Tissue Motion Measure - a Biomarker for Perimuscular Connective Tissue Pathology.
NCT01413997 is registered in ClinicalTrials.gov with Stromatec, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Study of Connective Tissue Motion Measure - a Biomarker for Perimuscular Connective Tissue Pathology.
- Lead sponsor
- Stromatec, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2011
- Completion date
- July 31, 2011
- Enrollment
- 39 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.